Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.995 USD | +3.10% | -4.82% | -40.44% |
05-15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.44% | 107M | |
+15.58% | 121B | |
+13.65% | 107B | |
-3.35% | 24.82B | |
+1.83% | 22.48B | |
-9.72% | 18.32B | |
-42.28% | 16.33B | |
-16.05% | 15.31B | |
+4.36% | 14.08B | |
+25.81% | 11.74B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Transcript : PDS Biotechnology Corporation, Q3 2022 Earnings Call, Nov 14, 2022